Analyst Reaffirms Buy Rating for Zevra Therapeutics with 15 Price Target
On March 5, 2024, analyst Oren Livnat from HC Wainwright & Co. reiterated a bullish stance on Zevra Therapeutics (NASDAQ: ...
© 2024 Stocks Today
Tag: ZVRA
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Unlocking the Future: The Rise of Open-Source FPGA Development Tools
-
The Future of Secure Communications: How Quantum-Resistant Encryption is Revolutionizing Wireless Technology
-
The Booming Market of Plant-Based Pharmaceuticals for Neurological Conditions
-
Office Real Estate Investment Trusts REITs WellPositioned for ReturntoWork Trend